(Q36690960)

15 August 2017

1 reference

title

Diagnostic criteria for polycystic ovarian syndrome (English)

1 reference

15 August 2017

Broekmans FJ

1

1 reference

15 August 2017

Fauser BC

series ordinal

2

1 reference

15 August 2017

publication date

1 August 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

30

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

3-11

1 reference

Polycystic ovary syndrome

15 August 2017

cites work

1 reference

12 December 2020

Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility

1 reference

12 December 2020

Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

1 reference

12 December 2020

Defects in beta-cell function in functional ovarian hyperandrogenism

1 reference

12 December 2020

Polycystic ovary syndrome

1 reference

12 December 2020

Components of the "metabolic syndrome" and incidence of type 2 diabetes.

1 reference

12 December 2020

The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest.

1 reference

12 December 2020

Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives

1 reference

12 December 2020

Diagnostic criteria for polycystic ovary syndrome: a reappraisal.

1 reference

12 December 2020

Pregnancy complications in PCOS.

1 reference

12 December 2020

Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones

1 reference

12 December 2020

Endometrial hyperplasia in young women

1 reference

12 December 2020

The polycystic ovary. I. Clinical and histologic features

1 reference

12 December 2020

Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called "hyperthecosis".

1 reference

12 December 2020

Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease

1 reference

12 December 2020

Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone

1 reference

12 December 2020

Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.

1 reference

12 December 2020

Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome.

1 reference

12 December 2020

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

1 reference

12 December 2020

Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population

1 reference

12 December 2020

Recalled menarche in relation to infertility and adult weight and height

1 reference

12 December 2020

Polycystic ovary syndrome: a risk for coronary artery disease?

1 reference

12 December 2020

Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries

1 reference

12 December 2020

Platelet Dysfunction in Lean Women with Polycystic Ovary Syndrome and Association with Insulin Sensitivity

1 reference

12 December 2020

Endometrial carcinoma; ovarian dysfunction--a risk factor in young women

1 reference

12 December 2020

Evidence for increased androsterone metabolism in some normoandrogenic women with acne

1 reference

12 December 2020

Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome

1 reference

12 December 2020

A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study

1 reference

12 December 2020

Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome

1 reference

12 December 2020

Current recommendations for the diagnostic evaluation and follow-up of patients presenting with symptomatic polycystic ovary syndrome

1 reference

12 December 2020

Definitions of the insulin resistance syndrome: the 1st World Congress on the Insulin Resistance Syndrome.

1 reference

12 December 2020

Anti-müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries

1 reference

12 December 2020

Ultrasound assessment of the polycystic ovary: international consensus definitions.

1 reference

12 December 2020

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

1 reference

12 December 2020

Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization

1 reference

12 December 2020

Genetic contributions to glucose intolerance in polycystic ovary syndrome

1 reference

12 December 2020

CLINICAL AND BIOCHEMICAL FEATURES OF POLYCYSTIC OVARIAN DISEASE.

1 reference

12 December 2020

Polycystic ovary syndrome and endometrial carcinoma

1 reference

12 December 2020

Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome

1 reference

12 December 2020

Birth weight and age at menarche in patients with polycystic ovary syndrome or diminished ovarian reserve, in a retrospective cohort

1 reference

12 December 2020

Polycystic ovary syndrome is associated with endothelial dysfunction

1 reference

12 December 2020

1 reference

12 December 2020

Association of insulin resistance with hyperandrogenia in women

1 reference

12 December 2020

Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study

1 reference

12 December 2020

Association between ovarian changes assessed by transvaginal sonography and clinical and endocrine signs of the polycystic ovary syndrome.

1 reference

12 December 2020

Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome

1 reference

12 December 2020

Screening women with polycystic ovary syndrome for metabolic syndrome

1 reference

12 December 2020

Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study

1 reference

12 December 2020

Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.

1 reference

12 December 2020

Clinical implications of hyperinsulinaemia in women

1 reference

12 December 2020

Obesity and weight loss in polycystic ovary syndrome

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS).

1 reference

12 December 2020

A comment on the European Society of Human Reproduction and Embryology/American Society for Reproductive Medicine consensus of the polycystic ovarian syndrome

1 reference

12 December 2020

Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment

1 reference

12 December 2020

Long-term health consequences of PCOS.

1 reference

12 December 2020

Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options

1 reference

12 December 2020

Pathogenesis of polycystic ovary syndrome--the enigma unravels?

1 reference

12 December 2020

Transvaginal ultrasound imaging, histopathology and endocrinopathy in patients with polycystic ovarian syndrome

1 reference

12 December 2020

A critical evaluation of simple methods for the estimation of free testosterone in serum.

1 reference

12 December 2020

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

1 reference

12 December 2020

Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management

1 reference

12 December 2020

How to discriminate between normal and polycystic ovaries: transvaginal US study

1 reference

12 December 2020

Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome

1 reference

12 December 2020

Vascular dysfunction and metabolic parameters in polycystic ovary syndrome

1 reference

12 December 2020

Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women

1 reference

12 December 2020

Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome

1 reference

12 December 2020

New approach to polycystic ovary syndrome and other forms of anovulatory infertility

1 reference

12 December 2020

11 beta-hydroxylase deficiency in hyperandrogenism

1 reference

12 December 2020

Pulsatile luteinizing hormone patterns in the follicular phase of the menstrual cycle, polycystic ovarian disease (PCOD) and non-PCOD secondary amenorrhea

1 reference

12 December 2020

Accuracy of ultrasound measurements of female pelvic organs

1 reference

12 December 2020

Serum inhibin B in polycystic ovary syndrome: regulation by insulin and luteinizing hormone

1 reference

12 December 2020

Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome

1 reference

12 December 2020

American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome: 25-26 August 2002, Washington, DC

1 reference

12 December 2020

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

1 reference

12 December 2020

Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients

1 reference

12 December 2020

Diagnostic evaluation of hyperprolactinemia.

1 reference

12 December 2020

Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis.

1 reference

12 December 2020

Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study

1 reference

12 December 2020

Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses

1 reference

12 December 2020

Androgen conjugates: physiology and clinical significance

1 reference

12 December 2020

Formation and early development of follicles in the polycystic ovary

1 reference

12 December 2020

What is polycystic ovary syndrome? Are national views important?

1 reference

12 December 2020

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

12 December 2020

Androgen-secreting adrenal adenomas

1 reference

12 December 2020

Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study

1 reference

12 December 2020

Clinical assessment of body hair growth in women

1 reference

12 December 2020

Differential diagnosis and imaging in Cushing's syndrome

1 reference

12 December 2020

Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome

1 reference

12 December 2020

Metformin administration improves endothelial function in women with polycystic ovary syndrome

1 reference

12 December 2020

The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome

1 reference

12 December 2020

Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome?

1 reference

12 December 2020

Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome

1 reference

12 December 2020

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

1 reference

12 December 2020

Mortality of women with polycystic ovary syndrome at long-term follow-up

1 reference

12 December 2020

Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries

1 reference

12 December 2020

Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters

1 reference

12 December 2020

Association between polycystic ovary syndrome and glucose intolerance during pregnancy

1 reference

12 December 2020

Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome

1 reference

12 December 2020

Endometrial cancer in young, normal-weight women

1 reference

12 December 2020

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

1 reference

12 December 2020

Hyperprolactinaemia in hypothyroidism: clinical significance and impact of TSH normalization

1 reference

12 December 2020

Identifiers

DOI

10.1385/ENDO:30:1:3

1 reference

Dimensions Publication ID

15 August 2017

1038100625

0 references

1 reference